These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28658650)

  • 1. The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.
    Bolm L; Cigolla S; Wittel UA; Hopt UT; Keck T; Rades D; Bronsert P; Wellner UF
    Transl Oncol; 2017 Aug; 10(4):578-588. PubMed ID: 28658650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
    Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
    Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-regulated integrin α
    Franco-Barraza J; Francescone R; Luong T; Shah N; Madhani R; Cukierman G; Dulaimi E; Devarajan K; Egleston BL; Nicolas E; Katherine Alpaugh R; Malik R; Uzzo RG; Hoffman JP; Golemis EA; Cukierman E
    Elife; 2017 Jan; 6():. PubMed ID: 28139197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression.
    Iwamoto C; Ohuchida K; Shinkawa T; Okuda S; Otsubo Y; Okumura T; Sagara A; Koikawa K; Ando Y; Shindo K; Ikenaga N; Nakata K; Moriyama T; Miyasaka Y; Ohtsuka T; Eto M; Akashi K; Nakamura M
    Cancer Lett; 2021 Aug; 512():15-27. PubMed ID: 33961925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition.
    Cannone S; Greco MR; Carvalho TMA; Guizouarn H; Soriani O; Di Molfetta D; Tomasini R; Zeeberg K; Reshkin SJ; Cardone RA
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer.
    Zhang Z; Qin Y; Ji S; Xu W; Liu M; Hu Q; Ye Z; Fan G; Yu X; Liu W; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):997-1008. PubMed ID: 34117747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer.
    Zhang J; Chen M; Fang C; Luo P
    Front Oncol; 2022; 12():1052132. PubMed ID: 36465388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts' Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Awaji M; Singh RK
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer.
    Peiffer R; Boumahd Y; Gullo C; Crake R; Letellier E; Bellahcène A; Peulen O
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer.
    Morgan A; Griffin M; Kameni L; Wan DC; Longaker MT; Norton JA
    Biology (Basel); 2023 Jul; 12(8):. PubMed ID: 37626931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment.
    Norton J; Foster D; Chinta M; Titan A; Longaker M
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32466266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
    Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
    Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast phenotype.
    Axemaker H; Plesselova S; Calar K; Jorgensen M; Wollman J; de la Puente P
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119801. PubMed ID: 39038611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stromal cancer-associated fibroblasts in pancreatic cancer.
    von Ahrens D; Bhagat TD; Nagrath D; Maitra A; Verma A
    J Hematol Oncol; 2017 Mar; 10(1):76. PubMed ID: 28351381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line.
    Tanaka R; Kimura K; Eguchi S; Ohira G; Tanaka S; Amano R; Tanaka H; Yashiro M; Ohira M; Kubo S
    BMC Cancer; 2022 Jul; 22(1):748. PubMed ID: 35804329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.